investors.biogen.comBiogen | Investor Relations
investors.biogen.com Profile
investors.biogen.com
Maindomain:biogen.com
Title:Biogen | Investor Relations
Description:The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts.
Discover investors.biogen.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investors.biogen.com Information
Website / Domain: |
investors.biogen.com |
HomePage size: | 48.485 KB |
Page Load Time: | 0.297009 Seconds |
Website IP Address: |
184.50.88.75 |
Isp Server: |
Akamai Technologies Inc. |
investors.biogen.com Ip Information
Ip Country: |
United States |
City Name: |
San Jose |
Latitude: |
37.339389801025 |
Longitude: |
-121.89495849609 |
investors.biogen.com Keywords accounting
investors.biogen.com Httpheader
Accept-Ranges: bytes |
Content-Encoding: gzip |
Content-Language: en |
Content-Security-Policy: report-uri //report-csp-violation |
Content-Type: text/html; charset=UTF-8 |
device: desktop |
ETag: "1579900567" |
From-Origin: same |
Last-Modified: Fri, 24 Jan 2020 21:16:07 GMT |
Link: http://investors.biogen.com/; rel="shortlink", http://investors.biogen.com/; rel="canonical", http://investors.biogen.com/investor-relations; rel="alternate"; hreflang="en", http://investors.biogen.com/investor-relations; rel="revision" |
Server: nginx |
X-Age: 1307 |
X-Cache-Hits: 4 |
X-Content-Security-Policy: report-uri //report-csp-violation |
X-Content-Type-Options: nosniff |
X-Drupal-Dynamic-Cache: UNCACHEABLE |
X-Frame-Options: SAMEORIGIN |
X-Generator: Drupal 8 (https://www.drupal.org) |
X-Request-ID: v-bc928288-3eee-11ea-a8cf-ab8f2d96ea6c |
X-UA-Compatible: IE=edge |
X-WebKit-CSP: report-uri //report-csp-violation |
X-XSS-Protection: 1; mode=block |
Content-Length: 11361 |
X-EdgeConnect-MidMile-RTT: 43, 43 |
X-EdgeConnect-Origin-MEX-Latency: 38, 38 |
Cache-Control: public, max-age=0, s-maxage=1800 |
Expires: Fri, 24 Jan 2020 21:37:55 GMT |
Date: Fri, 24 Jan 2020 21:37:55 GMT |
Connection: keep-alive |
Vary: Accept-Encoding |
Set-Cookie: DrupalVisitorMobile=0; path=/ |
investors.biogen.com Meta Info
charset="utf-8"/ |
content="Biogen | Investor Relations" name="title"/ |
content="Biogen" property="og:site_name"/ |
content="website" property="og:type"/ |
content="The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts." name="description"/ |
content="http://investors.biogen.com/investor-relations" property="og:url"/ |
content="Investor Relations | Biogen" property="og:title"/ |
content="no-referrer" name="referrer"/ |
content="The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts." property="og:description"/ |
content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
content="width" name="MobileOptimized"/ |
content="true" name="HandheldFriendly"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
184.50.88.75 Domains
investors.biogen.com Similar Website
Domain |
WebSite Title |
apps.prsa.org | Public Relations Resources & PR Tools for Communications Professionals: Public Relations Society of |
jobs.prsa.org | Public Relations Jobs - Public Relations Society of America (PRSA) |
uti.investorroom.com | Universal Technical Institute's Investor Relations - UTI Investor Relations |
investor.choicehotels.com | Choice Hotels International - Investor Relations Home - Investor Relations |
eqbank.investorroom.com | Equitable Bank Investor Relations - Investor Relations - Overview |
ir.americanexpress.com | Investor Relations - American Express Investor Relations |
51talk.investorroom.com | 51Talk Investor Relations - Investor Relations Home |
alumni.vt.edu | Alumni Relations | Alumni Relations | Virginia Tech |
ir.armstrong.com | Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
investor.littelfuse.com | Investor Relations | Investor Relations | Littelfuse |
career.mst.edu | Career Opportunities and Employer Relations – Career Opportunities and Employer Relations |
Missour |
humanrelations.lausd.net | Human Relations, Diversity and Equity / Human Relations, Diversity and Equity Home |
erd.dli.mt.gov | Employment Relations |
investor.ti.com | Investor relations | TI.com |
alumni.se.edu | Alumni Relations - Alumni Relations |
investors.biogen.com Traffic Sources Chart
investors.biogen.com Alexa Rank History Chart
investors.biogen.com Html To Plain Text
Skip to main navigation Top bar Biogen.com Information Request Sign up for Alerts Search Investor Relations Overview News Events & Presentations Events Presentations Financials SEC Filings Annual Reports Stock Information Stock Quote & Chart Analyst Coverage Investor FAQs Corporate Governance Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board Investors Overview Investor Relations Biogen Inc. Jan 24, 2020 4:16 PM EST Volume Today's Open Previous Close 52 Week High 52 Week Low Copyright West LLC. Minimum 15 minutes delayed. Corporate Profile At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp, and today has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics, and is focused on advancing research programs in multiple sclerosis and neuroimmunology, neuromuscular disorders, movement disorders, Alzheimer’s disease and dementia, ophthalmology, immunology, neurocognitive disorders, acute neurology, and pain. For investor inquiries related to the Nightstar Therapeutics acquisition, please contact Biogen Investor Relations at IR@biogen.com . The Latest News January 13, 2020 Biogen to Acquire Novel Clinical Stage Asset with Application in Alzheimer’s Disease and Parkinson’s Disease from Pfizer Inc. December 18, 2019 Biogen to Report Fourth Quarter and Year-End 2019 Financial Results January 30, 2020 December 17, 2019 Biogen to Present at the 38th Annual J.P. Morgan Healthcare Conference View All News Releases Webcasts and Replays Q4 and Full Year 2019 Earnings Call Webcast Jan 30, 2020 at 8:00 AM EST View all Events Download 2018 Annual Report View all SEC filings Footer Investors Careers Our Stories Contact Us Follow us Bottom Privacy Policy Terms & Conditions Forward-Looking Statements Community Guidelines Investor Relations Overview News Events & Presentations Events Presentations Financials SEC Filings Annual Reports Stock Information Stock Quote & Chart Analyst Coverage Investor FAQs Corporate Governance Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board Top bar Biogen.com Information Request Sign up for Alerts Search Follow us...
investors.biogen.com Whois
"domain_name": [
"BIOGEN.COM",
"biogen.com"
],
"registrar": "CSC CORPORATE DOMAINS, INC.",
"whois_server": "whois.corporatedomains.com",
"referral_url": null,
"updated_date": "2019-04-11 05:35:23",
"creation_date": "1995-04-14 04:00:00",
"expiration_date": "2020-04-15 04:00:00",
"name_servers": [
"NS1.P28.DYNECT.NET",
"NS2.P28.DYNECT.NET",
"NS3.P28.DYNECT.NET",
"NS4.P28.DYNECT.NET",
"ns3.p28.dynect.net",
"ns1.p28.dynect.net",
"ns4.p28.dynect.net",
"ns2.p28.dynect.net"
],
"status": [
"clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited"
],
"emails": [
"domainabuse@cscglobal.com",
"domainnamesadmin@biogen.com"
],
"dnssec": "unsigned",
"name": "Biogen Idec MA Inc",
"org": "Biogen Idec MA Inc",
"address": null,
"city": "Cambridge",
"state": "Ma",
"zipcode": "02142",
"country": "US"